Cancer cells subvert host immune surveillance by altering immune checkpoint (IC) proteins.
Some Epstein−Barr virus (EBV)-associated tumors have higher Programmed Cell Death …

Several kinase inhibitors that target aberrant signaling pathways in tumor cells have been
deployed in cancer therapy. However, their impact on the tumor immune microenvironment …

Patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
can experience life-threatening respiratory distress, blood pressure dysregulation, and …

Acute myeloid leukaemia (AML) is a lethal haematological malignancy characterized by an
immunosuppressive milieu in the tumour microenvironment (TME) that fosters disease …

The potential for the immune system to target hematological malignancies is demonstrated
in the allogeneic transplant setting, where durable responses can be achieved. However, …

Background Patients with cancer were excluded from phase 3 COVID-19 vaccine trials, and
the immunogenicity and side effect profiles of these vaccines in this population is not well …

Clinical manifestations of severe COVID-19 include coagulopathies that are exacerbated by
the formation of neutrophil extracellular traps (NETs). Here, we report that pulmonary …

Multiple myeloma ( MM ) is a lethal haematological malignancy that arises in the context of a
tumour microenvironment that promotes resistance to apoptosis and immune escape. In the …

The mechanisms explaining progression to severe COVID-19 remain poorly understood. It
has been proposed that immune system dysregulation/over-stimulation may be implicated, …

Multiple myeloma (MM) is characterized by progressive immune dysregulation, loss of
myeloma-specific immunity, and an immunosuppressive milieu that fosters disease growth and …